Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
472,561
-
Share change
-
+157,261
-
Total reported value
-
$3,034,000
-
Price per share
-
$6.45
-
Number of holders
-
19
-
Value change
-
+$2,076,284
-
Number of buys
-
13
-
Number of sells
-
4
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2018
As of 30 Sep 2018 IGC Pharma, Inc. - COM NEW (IGC) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 472,561 shares of stock of the company.
Largest 10 holders included Carroll Financial Associates, Inc., Creative Planning, HSBC HOLDINGS PLC, SUNTRUST BANKS INC, JANE STREET GROUP, LLC, ING GROEP NV, Cambridge Investment Research Advisors, Inc., CenterStar Asset Management, LLC, Advisor Group, Inc., and LADENBURG THALMANN FINANCIAL SERVICES INC..
This table shows 19 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.